Peter Beetham
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Peter Beetham
Non-Executive Director / Bio-Gene Technology
Dr Peter Beetham has over 30 years of experience in the bio-agriculture community.
He was employed by the Victorian Department of Agriculture and Rural Affairs (DARA) in Australia from 1985 to 1992, serving as a Scientific Officer based at the Plant Research Institute (PRI), working with research groups throughout Southeast Asia and the South Pacific. He continued his research as a postdoctoral scientist at the Boyce Thompson Institute at Cornell University, where he was one of the pioneers of the early work that led to the RTDS technologies.
Dr Beetham is the co-founder and chief executive of US-based agricultural biotechnology company Cibus Global LLC where he led the scientific and regulatory endeavours as R&D director. He has been president and chief executive of Cibus since July 2014. Prior to Cibus, he was the research director of plant and industrial products division at ValiGen, formerly Kimeragen Inc.
He was employed by the Victorian Department of Agriculture and Rural Affairs (DARA) in Australia from 1985 to 1992, serving as a Scientific Officer based at the Plant Research Institute (PRI), working with research groups throughout Southeast Asia and the South Pacific. He continued his research as a postdoctoral scientist at the Boyce Thompson Institute at Cornell University, where he was one of the pioneers of the early work that led to the RTDS technologies.
Dr Beetham is the co-founder and chief executive of US-based agricultural biotechnology company Cibus Global LLC where he led the scientific and regulatory endeavours as R&D director. He has been president and chief executive of Cibus since July 2014. Prior to Cibus, he was the research director of plant and industrial products division at ValiGen, formerly Kimeragen Inc.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 330th | Pengana International Equities | 27% | 6% |
| 538th | HHY Fund | 8% | 2% |
| 1553rd | Bio-Gene Technology | -55% | -16% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1038th |  | Bio-Gene Technology | $595k |
| 1298th | | Partners Group Global Income Fund | -$20.3m |
| 1299th | | Pengana International Equities | -$24.2m |
| 1302nd | | HHY Fund | -$27.9m |
| 1303rd |  | Ellerston Asian Investment | -$35.8m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Bio-Gene Technology | 29 Dec 2020 |
